Stoichiometry of active smad-transcription factor complexes on DNA
- PMID: 12374795
- DOI: 10.1074/jbc.M208532200
Stoichiometry of active smad-transcription factor complexes on DNA
Erratum in
- J Biol Chem. 2003 May 9;278(19):17580
Abstract
Transforming growth factor (TGF)-beta signals through a heteromeric complex of serine/threonine kinase receptors. The type I receptor phosphorylates and activates the receptor-regulated Smads (R-Smads), Smad2 and Smad3, which form hetero-oligomeric complexes with the co-Smad, Smad4, and translocate to the nucleus. Smad3 and Smad4 can bind directly to consensus DNA-binding elements in the promoters of target genes, whereas Smad2/Smad4 complexes are targeted to DNA by interacting with sequence-specific DNA-binding transcription factors that contain a well-defined Smad interaction motif (SIM). The exact stoichiometry of Smad homo- and hetero-oligomers both before and after ligand stimulation is controversial. Here we determine the stoichiometry of TGF-beta-induced Smad-transcription factor complexes on DNA. We show that complexes of Smad2/Smad4 with the transcription factors Fast-1 or Fast-3 contain one Fast, two Smad2s, and one Smad4. In contrast, Smad3/Smad4 complexes that bind the Smad-binding element from the c-jun promoter, are heterodimers. Furthermore, these Smad3/Smad4 complexes contain at least two additional components essential for complex formation, one of which contains a SIM. Our data suggest that the R-Smads can form heterodimers or heterotrimers with Smad4, and we propose that the exact stoichiometries of active Smad complexes on DNA may be determined by the transcription factors with which they associate.
Similar articles
-
Recognition of phosphorylated-Smad2-containing complexes by a novel Smad interaction motif.Mol Cell Biol. 2004 Feb;24(3):1106-21. doi: 10.1128/MCB.24.3.1106-1121.2004. Mol Cell Biol. 2004. PMID: 14729957 Free PMC article.
-
Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes.Dev Biol. 1999 Oct 15;214(2):354-69. doi: 10.1006/dbio.1999.9430. Dev Biol. 1999. PMID: 10525340
-
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.EMBO J. 1997 Sep 1;16(17):5353-62. doi: 10.1093/emboj/16.17.5353. EMBO J. 1997. PMID: 9311995 Free PMC article.
-
Intracellular signaling of the TGF-beta superfamily by Smad proteins.Ann N Y Acad Sci. 1999;886:73-82. doi: 10.1111/j.1749-6632.1999.tb09402.x. Ann N Y Acad Sci. 1999. PMID: 10667205 Review.
-
The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling.Mol Cell Endocrinol. 2001 Jun 30;180(1-2):3-11. doi: 10.1016/s0303-7207(01)00524-x. Mol Cell Endocrinol. 2001. PMID: 11451566 Review.
Cited by
-
Conformational landscape of multidomain SMAD proteins.Comput Struct Biotechnol J. 2021 Sep 14;19:5210-5224. doi: 10.1016/j.csbj.2021.09.009. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34630939 Free PMC article.
-
TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1.Cell Cycle. 2014;13(15):2400-14. doi: 10.4161/cc.29339. Cell Cycle. 2014. PMID: 25483191 Free PMC article.
-
Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.Mol Cell Biol. 2012 Jul;32(14):2904-16. doi: 10.1128/MCB.00231-12. Epub 2012 May 21. Mol Cell Biol. 2012. PMID: 22615489 Free PMC article.
-
The TGFBeta pathway as a therapeutic target in cancer.Clin Transl Oncol. 2008 Jan;10(1):14-9. doi: 10.1007/s12094-008-0148-2. Clin Transl Oncol. 2008. PMID: 18208788 Review.
-
Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.Biochem J. 2004 Apr 1;379(Pt 1):209-16. doi: 10.1042/BJ20031886. Biochem J. 2004. PMID: 14715079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
